| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/27/2006 | US20060166927 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 07/27/2006 | US20060166904 Prepared by hydrolysis of azithromycin derivatives to remove 4-O-methylcladinose from position 3 |
| 07/27/2006 | US20060166866 Cell adhesion inhibitors |
| 07/27/2006 | US20060165825 Pharmaceutical compositions |
| 07/27/2006 | US20060165816 Herbal compositions useful as chemopreventive and therapeutic agents |
| 07/27/2006 | US20060165771 Compositions for delivery of drug combinations |
| 07/27/2006 | US20060165721 Cinnamomi and poria composition, method to prepare same and uses thereof |
| 07/27/2006 | US20060165689 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 07/27/2006 | US20060165684 T-cell immune response cDNA 7 (TIRC7) antagonist; rheumatoid arthritis; comprising all three complementarity determining regions (CDRs) of the VH and all three complementarity determining regions (CDRs) of the VL variable regions; inhibiting proliferation of peripheral blood mononuclear cells |
| 07/27/2006 | DE102005002500A1 Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen Tetrahydrofuran derivatives as inhibitors of matrix metalloproteinases |
| 07/27/2006 | CA2595477A1 Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| 07/27/2006 | CA2594878A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | CA2594785A1 Crystalline forms cis-5-fluoro-n-[4-(2-hydroxy-4-methylbenzamido) cyclohexyl]-2-(tetrahydrothiopyran-a-yloxy) nicotinamide |
| 07/27/2006 | CA2594777A1 Indoles useful in the treatment of inflamation |
| 07/27/2006 | CA2594773A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | CA2594665A1 Thienopyrroles useful in the treatment of inflammation |
| 07/27/2006 | CA2594621A1 Pyrrolopyridines useful in the treatment of inflammation |
| 07/27/2006 | CA2593155A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | CA2562685A1 Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety |
| 07/26/2006 | EP1683796A1 Pyrazolopyridines, their preparation and their medical use |
| 07/26/2006 | EP1683795A1 Crystalline forms of cis-5-fluoro-N-¬4-(2-hydroxy-4-methylbenzamido)cyclohexyl|-2-(tetrahydrothiopyran-4-yloxy)nicotinamide |
| 07/26/2006 | EP1683526A1 Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac |
| 07/26/2006 | EP1683525A1 Sustained-release phenylalanine derivative preparation for oral administration |
| 07/26/2006 | EP1682551A2 Bicyclic pyrazolone cytokine inhibitors |
| 07/26/2006 | EP1682524A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 07/26/2006 | EP1682496A2 Analgesic compounds, their synthesis and pharmaceutical compositions containing them |
| 07/26/2006 | EP1682164A2 Cytokine antagonist molecules |
| 07/26/2006 | EP1682155A1 Analgesia method |
| 07/26/2006 | EP1682147A1 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes |
| 07/26/2006 | EP1682140A2 Methods of use of thrombin receptor antagonists |
| 07/26/2006 | EP1682135A1 Ccr-2 antagonist salt |
| 07/26/2006 | EP1682072A2 AChE ANTISENSE DEOXYOLIGONUCLEOTIDE AS AN ANTI-INFLAMMATORY AGENT |
| 07/26/2006 | EP1601672B1 Triazolo-pyridines as anti-inflammatory compounds |
| 07/26/2006 | EP1527063B1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 07/26/2006 | EP1513839B1 3-substituted quinuclidines and their use |
| 07/26/2006 | EP1448552B1 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
| 07/26/2006 | EP1414447B1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 07/26/2006 | EP1397105B1 Compositions for inhibiting angiogenesis |
| 07/26/2006 | EP1392329B1 Use of sulodexide for the treatment of inflammatory bowel disease |
| 07/26/2006 | EP1390543B1 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 07/26/2006 | EP1381686B1 Inactivation of genes of the mep pathway |
| 07/26/2006 | EP1368299B1 Substituted c-cyclohexylmethylamine derivatives |
| 07/26/2006 | EP1351703B1 Use of a polypeptide comprising the extracellular domains of il-20ra and il-20rb for the treatment of inflammation |
| 07/26/2006 | EP1240313B1 Homologue enzymes of human heparanase and splice variants thereof |
| 07/26/2006 | EP1196161B1 Conjugated linoleic acid for treatment of cyclooxygenase-2 mediated inflammation and pain |
| 07/26/2006 | EP1162937B1 Compositions based on chondroitin sulphate and chitosan for preventing or treating rheumatic disorders by general administration |
| 07/26/2006 | EP0979817B1 Leukotriene a4 hydrolaze inhibitors |
| 07/26/2006 | CN1809575A Thienopyridone derivatives as kinase inhibitors |
| 07/26/2006 | CN1809570A [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 07/26/2006 | CN1809356A Use of indazole derivatives for the treatment of neuropathic pain |
| 07/26/2006 | CN1809346A Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor XA and VIIA inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then |
| 07/26/2006 | CN1807390A Non-steroid anti-inflammatory agent felbinac preparation method |
| 07/26/2006 | CN1806850A Transdermal drug delivery intensifier composition and its application in externally applied medicine |
| 07/26/2006 | CN1806843A Pharmaceutical composition for treating arthritis and method for preparing the same |
| 07/26/2006 | CN1806839A Preparation method of dragon's blood abnormity tablet and dragon's blood abnormity coating tablet |
| 07/26/2006 | CN1806838A Chinese medicinal liquor |
| 07/26/2006 | CN1806823A Externally applied wind-expelling Chinese medicinal composition plaster |
| 07/26/2006 | CN1806820A Chinese medicinal composition, preparation method and quality control method thereof |
| 07/26/2006 | CN1806816A Pharmaceutical composition for treating bone diseases and method for preparing the same |
| 07/26/2006 | CN1806810A Rheumatism treating medicine |
| 07/26/2006 | CN1806797A Ketoprofen medicinal composition for treating rheumatoid arthritis and preparation method thereof |
| 07/26/2006 | CN1266151C Naphthyridine derivatives |
| 07/26/2006 | CN1266149C Use of aspergillus fumigatus in preparing anti inflammatory immunosuppressant |
| 07/26/2006 | CN1266134C Fused-polycyclic compounds |
| 07/26/2006 | CN1265838C Injectable veterinary composition for small animals |
| 07/26/2006 | CN1265837C Dysmenorrhea treating Chinese traditional medicine |
| 07/26/2006 | CN1265823C Health-care spray for treating acute injury, chronic strain, rheumatalgia |
| 07/26/2006 | CN1265814C Tanacetum parthenium extract |
| 07/26/2006 | CN1265806C Medicinal composition for treating rheumatism |
| 07/26/2006 | CN1265712C Improved anti-inflammatory herbal composition and application method thereof |
| 07/25/2006 | US7081562 obtained by backcrossing a mouse whose function of immunoglobulin Fc gamma receptor IIB gene is deficient on its chromosome and a wild-type collagen-induced arthritis-susceptible DBA/1J mouse six times or more |
| 07/25/2006 | US7081513 Peptides having Chemotaxis Inhibitory Protein from Staphylococcus aureus (CHIPS) activity for diagnosis, prophylaxis and treatment of inflammation and HIV |
| 07/25/2006 | US7081476 Tocopherol enriched compositions for reducing IL6 levels |
| 07/25/2006 | US7081469 Therapy for neovascularization; antitumor agents; vision defects; antidiabetic agents; antiarthritic agents |
| 07/25/2006 | US7081468 Angiogenesis inhibitors; antitumor agents; skin disorders; antiarthritic agents |
| 07/25/2006 | US7081462 Imidazo-substituted compounds as p38 kinase inhibitors |
| 07/25/2006 | US7081460 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/25/2006 | US7081351 Immobilized and labeled; detection cell differentiation, cell proliferation; prevent binding to fibroblast growth factor |
| 07/25/2006 | US7081345 For use in diagnostic, prognostic, prophylactic or therapeutic formulation |
| 07/25/2006 | US7081239 Administering formulation comprising peptide YY or antagonists of receptors for peptide YY for manipulating the rate of upper gastrointestinal transit of a substance in a mammal having an intrinsic cholinergic afferent neural pathway |
| 07/25/2006 | CA2159603C Quinolines as type iv phosphodiesterase inhibitors |
| 07/25/2006 | CA2133140C Isoxazole derivatives |
| 07/20/2006 | WO2006076318A1 Monopotassium salt of an ikb kinase inhibitor |
| 07/20/2006 | WO2006075784A1 ANTI-α9 INTEGRIN ANTIBODY AND THE USE THEREOF |
| 07/20/2006 | WO2006075509A1 Endotoxin activity inhibitor |
| 07/20/2006 | WO2006075152A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/20/2006 | WO2006044687A3 Kinase inhibitors |
| 07/20/2006 | WO2006015060A3 Isoindoline compounds and methods of their use |
| 07/20/2006 | US20060161004 Quinoline derivatives for therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper-reactivity, cough, inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 07/20/2006 | US20060160904 Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| 07/20/2006 | US20060160864 Acrylamide derivative, process for producing the same, and use |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160846 Quinoline derivatives |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160804 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 07/20/2006 | US20060160797 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/20/2006 | US20060160771 Aminophosphonic acid derivatives, addition salts thereof and sip receptor modulators |
| 07/20/2006 | US20060160726 Cyclic agonists and antagonists of C5a receptors and G protein-coupled receptors |
| 07/20/2006 | US20060160159 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/20/2006 | US20060160145 Assay that makes use of the interaction of early pregnancy factor (EPF) or an EPF-related peptide with a human dorsal root receptor (hDRR) or hDRR related receptor; also useful to determine whether the test compound is an agonist or antagonist of hDRRs |